Smith+Nephew Dragged Down by Weak Sales in Knees and Emerging Markets

Smith+Nephew's logo

Smith+Nephew reported 3Q20 orthopedic revenue of USD $845.9 million, -2.7% vs. 3Q19. While the company improved sequentially from the second quarter, lower levels of competitive sports, weakness in emerging markets and significant knee replacement losses hobbled its recovery. Hip replacement sales performed well in the quarter as surgeons...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us